---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-053170"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:25:21.323620+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q3 2025 revenue $267.8M (+240% YoY), net income $55.4M vs loss $8.8M

## Summary
- Total revenue $267.8M for Q3 2025, up 240% YoY; hospital division revenue $260.2M, up 263% YoY.
- Net income attributable to Nutex of $55.4M in Q3 2025 vs net loss of $8.8M in Q3 2024; diluted EPS $7.76.
- Adjusted EBITDA attributable to Nutex of $98.5M in Q3 2025 vs $9.7M in Q3 2024.
- YTD 2025: revenue $723.6M (+225%), net income $59.0M vs loss $9.5M, adjusted EBITDA $243.0M.
- Regained Nasdaq compliance on Nov 19, 2025 after filing delinquent 10-Q; matter closed.

## SEC filing metadata
- accession: 0001628280-25-053170
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/0001628280-25-053170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/nutx-20251119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-053170
- JSON: https://secwatch.observer/filing/0001628280-25-053170.json
- Plain text: https://secwatch.observer/filing/0001628280-25-053170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.